Johns Hopkins University’s Barinthus Biotherapeutics BRNS Stock Holding History

Johns Hopkins University’s Portfolio BRNS Stock Details BRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.6K	Hold	122,237	–	–	0.01%	13
2025 Q4	$85.6K	Hold	122,237	–	–	0.01%	14
2025 Q3	$153K	Hold	122,237	–	–	0.01%	16
2025 Q2	$114K	Hold	122,237	–	–	0.01%	19
2025 Q1	$119K	Hold	122,237	–	–	﹤0.01%	15
2024 Q4	$148K	Hold	122,237	–	–	0.01%	14
2024 Q3	$145K	Hold	122,237	–	–	0.01%	14
2024 Q2	$171K	Hold	122,237	–	–	0.01%	16
2024 Q1	$291K	Buy	122,237 +14,269	+13%	+$40.3K	0.01%	17
2023 Q4	$398K	Hold	107,968	–	–	0.02%	16
2023 Q3	$334K	Hold	107,968	–	–	0.02%	13
2023 Q2	$222K	Hold	107,968	–	–	0.01%	12
2023 Q1	$242K	Hold	107,968	–	–	0.02%	13
2022 Q4	$254K	Hold	107,968	–	–	0.01%	10
2022 Q3	$345K	Hold	107,968	–	–	0.02%	12
2022 Q2	$480K	Hold	107,968	–	–	0.05%	10
2022 Q1	$561K	Hold	107,968	–	–	0.06%	11
2021 Q4	$1.2M	Buy	+107,968	New	+$1.36M	0.12%	10

Other funds holding BRNS

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

GLR Partners Columbia, Maryland $215M AUM

DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Johns Hopkins University's BRNS Position: Q1 2026 in Review

Johns Hopkins University held its Barinthus Biotherapeutics (BRNS) position steady in Q1 2026 at 122,237 shares worth $69.6K. The position accounts for 0.01% of the portfolio, ranked #13.

Johns Hopkins University first reported a position in BRNS in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.2M in Q4 2021. 14 funds tracked by Wall St. Rank hold BRNS as of Q1 2026.

Johns Hopkins University held 122,237 shares of Barinthus Biotherapeutics worth $69.6K as of Q1 2026.
Johns Hopkins University left its Barinthus Biotherapeutics share count unchanged in Q1 2026.
Barinthus Biotherapeutics made up 0.01% of Johns Hopkins University's portfolio in Q1 2026, its #13 holding.
Johns Hopkins University first reported a position in Barinthus Biotherapeutics in Q4 2021 and has held it in 18 quarters since.
Johns Hopkins University's Barinthus Biotherapeutics position peaked at $1.2M in Q4 2021.
14 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q1 2026.

Based on Johns Hopkins University's 13F filing for Q1 2026, filed 14 May 2026.